Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-20137 in Moderate-to-severe Plaque Psoriasis
NCT07879885Phase 2Recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Jul 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of QX004N in plaque psoriasis, sponsored by Hansoh Pharmaceutical Group. Started Jul 2025; status: recruiting.
02
Drugs
QX004N
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07879885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07879885.